Price: $151.40, Change: $+1.87, Percent Change: +1.25%
Related Articles
Research
Mizuho Downgrades Okta to Neutral From Outperform, Adjusts Price Target to $125 From $110
Okta (OKTA) has an average rating of overweight and mean price target of $118.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $129.54, Change: $-10.25, Percent Change: -7.33%
$OKTA
Research
BofA Securities Initiates Mobia Medical With Buy Rating, $16 Price Target
BofA Securities Initiates Mobia Medical With Buy Rating, $16 Price Target
$MOBI
Research
Lake Street Initiates Nutex Health at Buy With $235 Price Target
Lake Street Initiates Nutex Health at Buy With $235 Price Target
$NUTX